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Abstract 
Background & Aims: Sulfur-metabolizing microbes, which convert dietary sources 
of sulfur into genotoxic hydrogen sulfide (H2S), have been associated with de-
velopment of colorectal cancer (CRC). We identified a dietary pattern associ-
ated with sulfur-metabolizing bacteria in stool and then investigated its associ-
ation with risk of incident CRC using data from a large prospective study of men. 
Methods: We collected data from 51,529 men enrolled in the Health Professionals 
Follow-up Study since 1986 to determine the association between sulfur-me-
tabolizing bacteria in stool and risk of CRC over 26 years of follow-up. First, in a 
subcohort of 307 healthy men, we profiled serial stool metagenomes and meta-
transcriptomes and assessed diet using semiquantitative food frequency ques-
tionnaires to identify food groups associated with 43 bacterial species involved 
in sulfur metabolism. We used these data to develop a sulfur microbial dietary 
score. We then used Cox proportional hazards modeling to evaluate adherence 
to this pattern among eligible individuals (n = 48,246) from 1986 through 2012 
with risk for incident CRC. 
Results: Foods associated with higher sulfur microbial diet scores included increased 
consumption of processed meats and low-calorie drinks and lower consumption 
of vegetables and legumes. Increased sulfur microbial diet scores were associ-
ated with risk of distal colon and rectal cancers, after adjusting for other risk fac-
tors (multivariable relative risk, highest vs lowest quartile, 1.43; 95% confidence 
interval 1.14–1.81; P-trend = .002). In contrast, sulfur microbial diet scores were 
not associated with risk of proximal colon cancer (multivariable relative risk 0.86; 
95% CI 0.65–1.14; P-trend = .31). 
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Conclusions: In an analysis of participants in the Health Professionals Follow-up 
Study, we found that long-term adherence to a dietary pattern associated with 
sulfur-metabolizing bacteria in stool was associated with an increased risk of dis-
tal CRC. Further studies are needed to determine how sulfur-metabolizing bac-
teria might contribute to CRC pathogenesis. 
Keywords: Colorectal Carcinogenesis, Cancer Biogeography, Fecal Microbes, FFQ 
Abbreviations: BMI, body mass index; CRC, colorectal cancer; EC, Enzyme Com-
mission; FFQ, food frequency questionnaire; GI, gastrointestinal; H2S, hydrogen 
sulfide; HPFS, Health Professionals Follow-up Study; IBD, inflammatory bowel 
disease; MLVS, Men’s Lifestyle Validation Study.  
What you need to know
Background and context 
Sulfur-metabolizing microbes, which convert dietary sources 
of sulfur into genotoxic hydrogen sulfide, have been associ-
ated with development of colorectal cancer (CRC). 
New findings 
In an analysis of participants in the Health Professionals Fol-
low-up Study, we found that long-term adherence to a di-
etary pattern associated with sulfur-metabolizing bacteria 
in stool was associated with an increased risk of distal CRC. 
Limitations 
This study analyzed diets and stool from male health pro-
fessionals. Studies among different populations are needed, 
as well as investigations to identify the mechanisms through 
which sulfur-producing microbes might promote colorectal 
carcinogenesis. 
Impact 
Foods contributing to high sulfur microbial diet scores, in-
cluding increased intake of processed meats and low-calo-
rie drinks and fewer vegetables and legumes, are associated 
with development of distal CRC.  
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In the United States, colorectal cancer (CRC) is the third most fre-
quently occurring and third most lethal form of cancer,1 with most 
new diagnoses occurring among those without a clear genetic pre-
disposition.2 Thus, disease prevention through changes in lifestyle, 
such as dietary intake, is a high priority.3 Diet has been convincingly 
shown to be a determinant in the taxonomic makeup and metabolic 
activities of the human gut microbiome,4,5 but whether the well-estab-
lished diet-CRC relationship is mediated through alterations in spe-
cific microbes and patterns of community metabolism remains vastly 
underexplored.6 
Substantial experimental evidence links the presence and activity 
of sulfur-metabolizing microbes with increased microbial production 
of hydrogen sulfide (H2S). Sulfur-metabolizing microbes, most often 
bacteria, are a specialized group of phylogenetically diverse microbes 
with the capacity to metabolize organic compounds for energy, often 
while reducing dietary sulfur to H2S.7–9 These bacteria and their resul-
tant metabolites have been associated with CRC,10,11 whereas H2S itself 
may cause epithelial DNA damage,8 and promote alterations in im-
mune cell populations associated with inflammation7,11 and CRC.8,12,13 
Further, gut-derived H2S may fragment the mucus bilayer of the gas-
trointestinal tract. This barrier is typically held together by disulfide 
bonds that may be broken by excess H2S. This breach may precede 
tumorigenesis by exposing gut epithelium to immunogenic luminal 
bacteria.14–16 
Distinct foods may serve as critical inputs upstream of this process. 
Diets rich in processed animal meats, often at the expense of fiber 
sources, such as fruits and vegetables, likely provide proinflammatory 
sulfur-containing amino acids more conducive to the proliferation of 
these harmful bacteria.4 This pattern of intake has previously been as-
sociated with increased CRC risk.17–21 Conversely, a diet enriched with 
legumes and other vegetables may be associated with decreased pop-
ulations of sulfur-metabolizing bacteria.22–24 Further, these foods are a 
rich source of glucosinolates, sulfur-containing compounds with anti-
inflammatory and possibly cancer preventive properties, 25–27 and have 
previously been associated with both a reduction in risk of CRC and 
precancerous adenomas.19,26,28 
Thus, we performed a novel 2-stage study to clarify the role of sul-
fur-metabolizing bacteria in CRC. First, in a developmental subcohort 
of 307 men from the Men’s Lifestyle Validation Study (MLVS) nested 
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within the Health Professionals Follow-up Study (HPFS) with diet and 
longitudinal stool sampling with next-generation sequencing, we gen-
erated the sulfur microbial diet, a de novo pattern of dietary constit-
uents associated with the enrichment of sulfur-metabolizing bacteria 
in stool. We then used the larger HPFS as a testing cohort to prospec-
tively associate long-term adherence to this dietary pattern with risk 
of incident CRC among participants for whom we had collected de-
tailed information on long-term diet and other relevant exposures. 
Methods 
Overall Study Population 
The HPFS is an ongoing prospective cohort study of 51,529 US male 
podiatrists, dentists, physicians, veterinarians, pharmacists, and op-
tometrists aged 40 to 75 years at enrollment in 1986. Participants 
have been followed since inception with detailed biennial question-
naires on medical, lifestyle, and other health-related information. Di-
etary intake was assessed every 4 years through a semiquantitative 
food frequency questionnaire (FFQ). Follow-up among eligible sub-
jects exceeds 90% of available person-time. 
Nested within the HPFS, the MLVS was established among gener-
ally healthy participants, specifically excluding those with a prior his-
tory of coronary heart disease, prior cerebrovascular events, nonmel-
anoma cancer, or major neurologic comorbidities. Both cohorts have 
previously been described extensively. 29,30 We recruited the 307 male 
individuals in the MLVS who provided longitudinal stool samples be-
tween July 2012 and July 2013 (Figure 1). 
Developmental cohort (MLVS) 
Sample and data collection. MLVS participants were asked to provide 
stool samples from 2 consecutive bowel movements 24 to 72 hours 
apart, followed approximately 6 months later by collection of a sec-
ond, similarly paired set of samples. The collection protocol used has 
previously been detailed and validated to impart minimal perturbative 
effect from at-home collection of gut metagenomes and metatran-
scriptomes compared with fresh-frozen sample collections.31–33 Each 
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bowel movement was placed into a container with RNA later. Partici-
pants completed a questionnaire detailing the date and time of evac-
uation, Bristol stool scale, and other relevant metadata. Paired samples 
were stored at ambient temperature, at which point both were sent 
overnight to the Massachusetts General Hospital and the Harvard T.H. 
Chan School of Public Health and held in –80_C freezers until nucleic 
acid extraction for subsequent sequencing at the Broad Institute of 
MIT and Harvard. To obtain metagenomes and metatranscriptomes, 
we used the Illumina HiSeq paired-end (2 × 101 nucleotides) shot-
gun sequencing platform. RNA was extracted and sequenced from 
the subset of participants who provided stool during both sampling 
periods (initial and 6 months later) and did not report the use of an-
tibiotics within the past year. One individual was excluded from our 
analytic cohort after study enrollment because of prior history of to-
tal colectomy. 
Sequence bioinformatics. Taxonomic and functional profiles were 
generated using the bioBakery shotgun metagenome workflow 
v0.9.0.34 Shotgun metagenomes yielded relative taxonomic profiles 
using MetaPhlAn2 v2.6.0.35 Functional profiling was done using HU-
MAnN2 v0.11.0.36 For reads that did not map at the nucleotide level, 
a subsequent translated search was performed against a UniRef90-
based protein sequence catalog,37 resulting in final gene family abun-
dance tables for both metagenomic and metatranscriptomic profiles, 
stratified by species contribution. 
These gene families were then assembled into higher-order group-
ings, such as Enzyme Commission (EC) numbers. Species transcrip-
tional activity was also quantified by summing the total sum-nor-
malized stratified abundance attributed to each organism with the 
expression ratio defined as the ratio between species-stratified meta-
transcriptomic-to-metagenomic functional profiles. Only samples with 
greater than 1 read per kilobase of transcript per million mapped 
reads were used in downstream analysis. 
Identification of sulfur-modifying enzymes and sulfur-metabo-
lizing bacteria. First, we excluded microbial species that did not sur-
pass minimum prevalence (10% of samples) and abundance (0.1% 
relative abundance) thresholds in human stool. We then used 2 com-
plementary approaches to catalog sulfur-metabolizing bacteria: (1) a 
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MetaCyc version 22 pathway search38,39 for at least 2 reactions gen-
erating H2S in the bacterial pangenome, and (2) a comprehensive lit-
erature review. We derived relevant sulfur-metabolism enzymes and 
their EC numbers by searching BRENDA release 2018.139,40 and Meta-
Cyc version 22.38,39 “Hydrogen sulfide” with exact and synonymous 
matching was used to identify relevant reactions. In addition, to pre-
vent the inclusion of promiscuous enzymes not intimately involved in 
sulfur metabolism, we further refined our enzyme list to those that ac-
tively participate in sulfur group modification, for example, of a thiol 
(-SH) to a sulfide (-S-), and required that most of the reactions they 
catalyze to be sulfur metabolism reactions. The curated EC lists from 
BRENDA and MetaCyc were then merged and used for agnostic anal-
ysis (Supplementary Table 1). 
A given species was considered a sulfur-metabolizing bacterium 
if representative strains disclosed reactions that generated H2S or if 
there was prior, high-quality experimental evidence supporting that 
classification. Membrane, transport, unknown direction, and revers-
ible H2-generating reactions were excluded from the analysis. In some 
cases, microbial generation of H2S was deemed unlikely if robust ex-
perimental evidence of nonproduction, product uptake, or product 
use in biotransformation was observed. For some bacteria, H2S gen-
eration was extended from species to higher taxonomic levels if prior 
studies indicated this to be a core function among members. For ex-
ample, because Odoribacter splanchnicus is known to produce H2S,41 
this designation was extended to all members of the Odoribacter ge-
nus. Veillonella atypica, Veillonella parvula, and Veillonella unclassi-
fied were each categorized similarly.42 
Dietary information and the derivation of the sulfur microbial 
diet score. The validity and reproducibility of the FFQ used in this 
cohort have been previously reported. 43 Briefly, the FFQ includes 131 
food items with specified serving sizes using common portions (e.g., 
1 orange or 2–3 celery sticks) or standard weight and volume mea-
surements. For each item, participants indicated their average fre-
quency of consumption over the past year with regard to serving size 
and frequency ranging from “almost never” to “≥6 times/day,” which 
was then converted to servings/day. In the HPFS, the FFQ has been 
administered every 4 years since inception. 
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For the first stage, participants in the MLVS microbiome collection 
served as the developmental cohort to assess the dietary predictors 
of sulfur-metabolizing bacteria abundance. These participants were 
administered 2 additional FFQs (6 months apart). To dampen mea-
surement errors from random interindividual variance, their responses 
across both FFQs were averaged and used for de novo dietary deriva-
tion. After collapsing food items into servings/day for 40 predefined 
food groups formed on the basis of culinary usage and nutrient pro-
files, consistent with prior methods,44 we used reduced rank regression 
models and stepwise linear regression analyses to identify a dietary 
pattern of intake most predictive of the log-transformed abundance 
of our bacterial species of interest. 
Testing Cohort (HPFS) 
Assessing long-term adherence to the sulfur microbial diet. In the sec-
ond stage of our study, we calculated sulfur microbial diet scores for 
each participant in the much larger HPFS based on nearly 3 decades of 
diet data (1986–2010) by summing the intake of foods retained from 
the final stepwise linear regression analyses weighted by their regres-
sion coefficients. To represent long-term usual dietary habits, sulfur 
microbial diet scores were updated at each follow-up cycle using the 
cumulative average method, with each score averaged across all assess-
ments before the current questionnaire. The food-based sulfur micro-
bial diet score represents a data-driven prediction for how much sul-
fur-metabolizing bacteria an individual may harbor over the long-term. 
Colorectal cancer ascertainment. The primary endpoint was incident 
CRC. Participants prospectively reported new CRC diagnoses on bi-
ennial questionnaire or were identified through reporting from fam-
ily, postal authorities, or the National Death Index. Physicians blinded 
to risk factor status reviewed relevant medical records for case con-
firmation and to retrieve data on anatomic site, histologic features, 
and stage of presentation. 
Assessment of covariates. Height and weight were reported at study 
inception, and weight was updated biennially. Body mass index (BMI) 
was calculated as weight in kilograms/ height in meters2. Physical ac-
tivity was self-reported using validated questionnaires every 2 to 4 
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years.45 We also assessed and updated the age they started or stopped 
smoking, number of cigarettes smoked daily, family history of CRC 
among first-degree relatives, regular use of aspirin, prior health care 
engagement (visit to a care provider in the past 2 years), and prior 
history of lower gastrointestinal endoscopy. 
Statistical Analysis 
At baseline, we excluded participants with CRC, inflammatory bowel 
disease (IBD), or with missing information on dietary intake. We also 
excluded individuals reporting implausible energy intake (<800 or 
>4200 kcal/day). In total, 48,246 subjects comprised our final study 
population. Follow-up time accrued from study enrollment until the 
date of CRC diagnosis, death from any cause, or the end of follow-
up (January 31, 2012), whichever occurred first. We used Cox propor-
tional hazards models to estimate age and multivariable-adjusted rela-
tive risks and their 95% confidence intervals (CIs). Schoenfield residual 
testing confirmed no violations of the proportional hazards assump-
tion. Covariates were chosen a priori and updated on a time-varying 
basis among major CRC risk factors and confounders, including age 
(continuous), family history of CRC (yes/no), BMI (quartiles), physi-
cal activity (metabolic equivalent task hours/week, quartiles), smok-
ing (categories, never, past, current: 1–14, 15–25, and >25 cigarettes 
per day), regular aspirin use (yes/no), total caloric intake (continuous), 
prior endoscopy within the past 2 years, and physical examination/
health care engagement in the past 2 years (each yes/no). For miss-
ing data, we carried forward nonmissing covariate data from 1 pre-
vious data cycle. SAS version 9.4 (SAS, Inc., Cary, NC) and R 3.5.1 (Vi-
enna, Austria) were used for all statistical analyses. 
Regulatory Compliance and Data Availability 
Participant recruitment and study-related protocols were approved 
by the Harvard T. H. Chan School of Public Health Institutional Review 
Board #HSPH 22067-102. Informed consent was implied through vol-
untary return of study questionnaires and bio specimens. Sequencing 
data have been deposited in the Sequence Read Archive under Bio-
Project ID: PRJNA354235. Non–sequencing-based cohort data may 
be obtained with written request. 
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Results 
Developmental Cohort (MLVS) 
In our nested cohort of 307 men, mean age was 70.6 ± 4.3 years at 
the time of first stool collection. They generally did not smoke, con-
sumed alcohol in moderation, and stool was typically of normal con-
sistency by Bristol Stool Score (Supplementary Table 2).46 In the 12 
months before sampling, 26.6% of participants had been exposed to 
antibiotics, and 5.2% underwent bowel preparation within the prior 2 
months. We found no clinically important differences between those 
who elected to participate in the MLVS stool sample collection and 
those who did not on the basis of age (mean age 71 years), ethnicity 
(each 97% white), BMI (25.7 vs 25.6 kg/m2), physical activity (46 vs 50 
metabolic equivalent of tasks hours/wk), and smoking status (1.5 vs 
1% current smokers). 
DNA was extracted from 925 stool samples. RNA was reverse tran-
scribed to complementary DNA for the 340 samples from partici-
pants who provided stool at both sampling periods and did not re-
port the use of antibiotics within the past year (Figure 1). Before and 
after computational quality control, sequencing depth was 3.8 ± 1.6 
Figure 1. Experimental 
design. 
(A) Study population 
and sampling details. 
Participants in the 
MLVS provided up 
to 4 stool samples 
over a 6-month 
study period with 
measurement of 
dietary intake via FFQ, 
identical to the FFQ 
given to participants 
in the HPFS. 
Stool underwent 
metagenomic and 
metatranscriptomic 
sequencing. 
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(B) Creation of the sulfur 
microbial diet. In the first stage, 
among MLVS participants 
with longitudinal stool 
metagenomes and FFQs, we 
used supervised clustering 
and regression techniques 
to determine the foods most 
commonly associated with 
increased abundance of sulfur-
metabolizing bacteria to 
generate the sulfur microbial 
diet score. 
(C) Predicted microbial carriage 
and risk of CRC. In the second 
stage, leveraging access to the 
much larger HPFS cohort with 
diet assessed every 4 years 
since inception, as well as other 
factors that may confound 
the relationship between diet 
and CRC, we calculated sulfur 
microbial diet scores in all 
48,246 eligible participants of 
the HPFS, with higher scores 
reflecting closer adherence to 
a diet predicted to enrich for 
sulfur-metabolizing bacteria. 
ASA, aspirin or acetylsalicylic 
acid; SAA, sulfur-containing 
amino acids.   
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giganucleotides (Gnt) and 1.8 ± 0.7 Gnt for DNA and 2.8 ± 2.4 Gnt and 
1.2 ± 1.0 Gnt for RNA, respectively. We identified and retained 139 
bacterial species after minimum prevalence and abundance filtering, 
43 of which were deemed sulfur-metabolizing microbes on the basis 
of both prior supportive experimental evidence plus the presence of 
at least 2 sulfur-modifying enzymes in their respective pangenomes 
(Supplementary Table 3). 
We found modest concordance between the presence of sulfur-
metabolizing enzymes found in stool metagenomes (DNA) with their 
downstream expression (RNA from metatranscriptomes; Figure 2). 
This suggests that for reactions catalyzed by the subset of enzymes 
used to define sulfur-metabolizing microbes, the presence of species 
that encode for these gene products is generally reflective of and a 
reasonable proxy for the underlying sulfur-metabolizing activity of 
the human gut in stool. 
Using the FFQs collected most proximate to biospecimen collec-
tion, the sulfur microbial diet score was calculated using the weighted 
sum of the 7 food groups retained after stepwise linear regression and 
deemed most predictive of the log-transformed abundance of our 43 
sulfur-metabolizing species (Supplementary Table 4). The component 
food groups were processed meat, liquor, and low-calorie drinks (each 
positively associated with the relative abundance of sulfur-metaboliz-
ing bacteria), as well as beer, fruit juice, legumes, mixed (other) vege-
tables, and sweets/desserts (each negatively associated). 
We found notable relationships between sulfur microbial diet scores 
and the abundance of 2 sulfur-metabolizing bacteria previously identi-
fied as important microbes in the CRC microbiome. Specifically, sulfur 
microbial diet scores were associated with relative enrichments for Ery-
sipelotrichaceae bacterium 21_3 and Bilophila wadsworthia (Figure 3). 
E bacterium 21_3, of the Firmicutes phylum, has previously been 
shown to be increased in mice fed high-fat diets,47–50 as well as in pa-
tients with CRC.47 Several Bilophila spp are overrepresented in CRC and 
precursor colonic adenoma tissue, particularly from African American 
patients.51,52 
Some sulfur-metabolizing enzymes were carried and expressed only 
by a single species, such as B wadsworthia and EC 1.8.99.3 (hydrogen 
sulfite reductase), a major contributor to dissimilatory sulfite reduc-
tion and an important proxy for microbially driven H2S production 
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(Figure 4).53 Conversely, enzymes such as EC 2.7.7.4 (sulfate adeny-
lyltransferase), which catalyzes reactions to metabolize dietary sul-
fur and purine, were more widely shared among phylogenetically di-
verse microbes, including those from the Parabacteroides genera, 
Ruminococcus spp, and Desulfovibrio desulfuricans. This may indicate 
a community-level response to substrate availability through enrich-
ment of microbes capable of metabolizing the sulfur- and purine-rich 
Figure 2. Bar plot of correlation between sulfur-related enzyme functional potential 
(DNA) and functional activity (RNA). Modest concordance was observed between 
observed metagenomes and their downstream metatranscriptomes among enzymes 
intimately involved in sulfur modification and sulfur metabolism. This suggests that 
for reactions catalyzed by our subset of enzymes, the sulfur microbial diet trained 
on the species that encode for these gene products is reflective of the underlying 
sulfur-metabolizing activity of the human gut in stool. Only enzymes represented 
in both DNA and RNA with P < .05 shown.  
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processed meats that characterize the sulfur microbial diet. In general, 
for sulfur-metabolizing enzymes, microbial transcriptional activity was 
highly correlated with their metagenomic functional capacities, that is, 
the greater number of species encoding for a given sulfur-metaboliz-
ing enzyme at the DNA level, the greater the number of species that 
will contribute to that enzyme’s RNA level. This observation indicates 
the biological importance of these enzymes: when present, they are 
expressed. This supports the need to evaluate the entire community 
of microbes involved in sulfur economy, rather than several in com-
parative isolation. 
Figure 3. The association between the sulfur microbial diet and 2 representative 
sulfur-metabolizing bacteria. Higher sulfur microbial diet scores were associated 
with a relative enrichment of 2 sulfur-metabolizing microbes previously implicated 
in dysbiosis-associated CRC, Bilophila wadsworthia and Erysipelotrichaeceae bacte-
rium. Trend line fit to nonzero data.  
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Testing Cohort (HPFS) 
After developing our de novo dietary pattern among individuals with 
dietary inventories during longitudinal stool sampling, we calculated 
sulfur microbial diet scores for each participant in the much larger 
HPFS based on their FFQs collected serially from 1986 to 2010. We 
found that participants more closely adhering to the sulfur microbial 
diet tended to have a slightly higher BMI, more frequently smoked 
(currently and in the past), and were more likely to be regular users 
of aspirin (Table 1). We sought to ensure the sulfur microbial diet was 
not serving as a surrogate measure for a Western-style diet, a diet 
characterized by high-fat intake and deficient in fiber, and a pattern 
Figure 4. Contributional genetic diversity among sulfur-metabolizing enzymes by 
sulfur-metabolizing bacteria. Enzymes are arranged along the x-axis from least to 
greatest number of attributable species encoding for it at the DNA level (EC 1.8.1.8 
= 1 species, EC 2.8.1.7 = 36 species). In general, the greater number of species en-
coding for a given enzyme (DNA), the greater the number of species that will con-
tribute to that enzyme’s functional activity or transcript level. Only ECs with 1 or 
more assignable taxon for both DNA and RNA are shown.  
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of intake previously associated with CRC risk.19,54 Despite sharing sev-
eral food groups, sulfur microbial diet scores were not associated with 
Western dietary scores (Spearman ρ = –0.009 at study baseline), sug-
gesting sulfur microbial diet scores capture a novel, independent sig-
nal within the well-established diet-CRC relationship. 
We documented 1264 cases of incident CRC over 26 years of fol-
low-up encompassing 1,077,325 person-years. Greater adherence to 
the sulfur microbial diet was associated with an increased risk of dis-
tal colon and rectal cancer (Figure 5). Compared with having a sul-
fur microbial diet score in the first quartile, men in the highest quar-
tile had a multivariable relative risk of 1.43 (95% confidence interval 
1.13–1.81; P-trend = .002), after adjusting for putative CRC risk factors. 
In contrast, no clear association was observed for proximal colorec-
tal cancer (P-trend = 0.31). 
Table 1. Baseline Age-Standardized Characteristics by Sulfur Microbial Diet Score (HPFS, 
1986) 
                      Sulfur microbial diet score 
 Quartile 1  Quartile 2   Quartile 3  Quartile 4  
 (n = 12,035) (n = 12,240) (n = 12,004) (n = 11,967) 
Age, y  54.2 (10.0)  54.2 (9.9)  54.3 (9.8)  54.0 (9.6) 
BMI, kg/m2  24.9 (3.1)  25.2 (3.1)  25.6 (3.2)  26.3 (3.5) 
Alcohol intake, g/d  13.0 (17.3)  8.3 (10.8)  8.4 (11.3)  16.0 (19.2) 
Physical activity, MET-h/wk  21.7 (28.3)  18.7 (24.8)  17.7 (26.6)  17.0 (24.1) 
Past smokers, %  39 40 42 47 
Current smokers, %  8  7  9  13 
Regular aspirin use, %  28  29  28  31 
Family history of colorectal cancer, %  15  15  14  14 
White race, %  96  96  95  96 
Screening lower endoscopy within past 2 y, %  27  28  27  26 
Calories, kcal/d  2339 (629)  1964 (557)  1798 (550)  1846 (588) 
Dietary intake (servings/wk) 
Processed meats  1.9 (2.1)  2.0 (2.1)  2.4 (2.3)  4.0 (4.3) 
Liquor  1.1 (2.5)  1.3 (2.7)  1.8 (3.6)  5.6 (8.3) 
Low-calorie drinks  1.3 (2.8)  1.7 (3.1)  2.6 (3.9)  8.4 (10.5) 
Beer  4.3 (7.5)  1.5 (2.6)  1.0 (2.0)  1.0 (1.9) 
Fruit juice  8.5 (8.7)  5.8 (4.8)  4.3 (3.9)  3.7 (3.9) 
Legumes  4.9 (3.4)  3.1 (1.9)  2.4 (1.6)  2.2 (1.6) 
Other vegetables  5.4 (4.3)  3.7 (2.6)  2.9 (2.1)  2.7 (2.1) 
Sweets & desserts  11.9 (12.1)  7.1 (6.3)  5.3 (5.0)  4.8 (5.2) 
All values other than age have been directly standardized to age distribution (in 5-year age group) of all 
participants. 
Mean (standard deviation) is presented for continuous variables. 
MET, metabolic equivalent of tasks.
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Further analyses by subgroups were notable for several reasons. 
When comparing extreme quartiles of sulfur microbial diet scores, the 
association was stronger among subjects without a family history of 
CRC (P-interaction = .02; Figure 6). Similarly, those with a lower BMI 
and no prior history of smoking were at greater risk for distal colon 
and rectal cancer than their referent counterparts. Taken together, this 
could suggest that adherence to the sulfur microbial diet may have an 
outsized influence on disease risk among those with few or no prior 
CRC risk factors. 
Figure 5. Sulfur microbial diet and risk of CRC. Multivariable modeling demonstrat-
ing an association between increased adherence to the sulfur microbial diet and risk 
of distal colon and rectal cancer. Models adjusted for age, family history of CRC, BMI, 
physical activity, smoking, aspirin use, total caloric intake, prior endoscopy, and re-
cent physical examination. Tests for trend were conducted using the median value 
of each quartile category as a continuous variable. RR, relative risk.  
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Conclusions 
Our study, composed of the MLVS subcohort nested within the much 
larger, prospective HPFS, offered a unique opportunity to not only 
explore the dietary determinants of sulfur-metabolizing bacteria, but 
how human gut communities enriched for these microbes may cor-
respond with disease risk. We linked predicted long-term enrichment 
for these bacteria using a de novo dietary-based index, the sulfur mi-
crobial diet score, to increased risk for distal CRC. Interestingly, the 
sulfur microbial diet was more closely aligned with elevated risk for 
CRC among individuals with fewer traditional CRC risk factors. Taken 
together, we offer first-of-its-kind evidence linking targeted microbi-
ome discovery with diet-driven differences in disease risk at an epide-
miologic scale, implicating gut microbial communities as a potential 
intermediary in the well-established diet-to- CRC relationship. These 
results may provide a rationale for considering dietary modification 
as a means to modulate long-term ecological states implicated in an 
array of GI diseases, including CRC and the IBDs. 
Figure 6. Sulfur microbial diet and risk of overall CRC and distal colon and rectal 
cancer by various subgroups. Multivariable relative risks comparing extreme quar-
tiles of sulfur microbial diet scores were adjusted for age, family history of CRC, BMI, 
physical activity, smoking, aspirin use, total caloric intake, prior endoscopy, and re-
cent physical examination with the exception of a given stratification variable.  
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Our primary findings were motivated by a collection of long-stand-
ing mechanistic factors that relate colonic nutrients to microbial bio-
chemistry. A mucus bilayer in the colon partitions epithelial cells from 
the microbial contents of the gut. This typically sterile fortification 
separates primed epithelial tissue from highly immunogenic micro-
bial antigens. Consequently, disruption of this interface is considered 
an important event in the development of CRC and IBD.55,56 The mu-
cins that comprise this barrier are joined by disulfide bonds, which 
are fragmented in the presence of excess H2S, a harmful byproduct 
of sulfur metabolism.14,16,57 This creates a breach in a crucial protective 
barrier. Other efforts have convincingly demonstrated how diet may 
modulate overall gut microbial composition.4,5,58 Prior cross-sectional 
evidence found that high-fat diets enriched for meat-based proteins 
may promote distinct and less diverse populations of sulfur-metabo-
lizing bacteria in humans.24 Processed meats, a key component of the 
sulfur microbial diet, are viewed as particularly problematic because 
of their high sulfur content from both sulfur-containing amino acids 
and the inorganic sulfurs found in preservatives.9 In contrast, plant-
based sulfur sources, such as those found in legumes and vegetables, 
2 food groups associated with the relative depletion of sulfur-me-
tabolizing bacteria, are distinct from animal-based sources, and may 
include compounds called glucosinolates. Non–sulfur-metabolizing 
bacteria may produce myrosinases that hydrolyze glucosinolates to 
isothiocyanates, which have been extensively studied for their cancer 
preventive properties.59–61 Thus, the source of sulfur, rather than quan-
tifiable sulfur content of foods, may be more strongly predictive for 
sulfur-metabolizing bacterial abundance, a plausible explanation for 
prior inconsistent findings relating overall sulfur content with CRC risk. 
In addition, our finding of elevated risk in the distal colorectum fits 
in the context of prior work in humans demonstrating CRC to be a 
molecular heterogeneous disease by anatomic site, suggesting there 
may be etiological differences among cancers arising from the proxi-
mal vs the distal large bowel.62 Prior animal studies have demonstrated 
differential expression of toll-like receptor-2 and toll-like receptor-4 
along the colorectum in specific-pathogen free, but not germ-free 
mice, suggesting that GI microbes may alter regional expression of 
these markers of innate immunity.63 Other investigations have also 
reaffirmed that patterns of host gene function may be altered by 
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microbial signals dependent on favorable anatomic conditions.64–66 
Amino acid fermentation, including sulfur-containing cysteine and 
methionine, may be greater in the distal, rather than the proximal co-
lon.67 Taken together, multiple host factors critical to maintaining im-
mune and microbial homeostasis decrease caudally and could pro-
mote the emergence of disease-promoting microbes, rendering the 
distal colorectum more susceptible to injury. The presented work adds 
a new dimension beyond traditional or well-established CRC risk fac-
tors with a proportion of attributable risk perhaps driven by biogeo-
graphical differences in microbial ecology (i.e., differences in the re-
gional and anatomical diversity of the gut microbiome).68 
This study expands on prior research in CRC and the gut microbi-
ome, which have largely focused on either diet or microbiology in iso-
lation. However, a collection of smaller scale or time-limited studies 
in humans,4,22,24 corroborating experimental evidence,9,69–71 and large-
scale investigations of the CRC microbiome with little information on 
dietary intake,23,72 have each substantiated the importance of sulfur-
metabolizing bacteria, which we identified using a comprehensive lit-
erature review complemented by agnostic bioinformatics approaches. 
In one such study, participants fed a high-meat, high-fat diet for sev-
eral days had an increase in bile-resistant sulfur-metabolizing bacteria 
and microbial DNA and RNA encoding for H2S -producing enzymes. 4 
In a large cohort of patients with precancerous polyps and CRCs, there 
was relative enrichment of sulfur-metabolizing microbes, including Bi-
lophila and Desulfovibrio spp, as well as sulfur-related pathways, all 
along the adenoma-carcinoma sequence.72 
Our study has several strengths. First, we leveraged a large, deeply 
characterized study population with more than 26 years of follow-
up, including a developmental cohort with contemporaneous dietary 
inventories and serial stool sampling. This allowed us to more com-
prehensively and longitudinally associate the intake of certain foods 
with the enrichment and depletion of sulfur-metabolizing bacteria, 
and subsequently link these putative foods and pattern of intake to 
risk for GI malignancy. Although H2S has long been believed to con-
tribute to inflammation and carcinogenesis, it exists in gaseous, dis-
solved, and anionic forms in the colonic environment, making it chal-
lenging to measure in vivo. These limitations are circumvented by 
observing the alterations in bacterial counts and their enzymatic ac-
tivity related to sulfur economy. Jointly incorporating metagenomic 
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taxonomic assignment with metatranscriptomic functional activity cur-
rently serve as the best available proxy for the genotoxic effects of 
H2S and allows us to more confidently assign the observed associa-
tion between the sulfur microbial diet and distal CRC to the micro-
bial metabolism of sulfur, rather than other functions also possessed 
by this class of bacteria. Second, information on dietary intake and 
cancer outcomes were regularly updated and collected prospectively 
with high follow-up rates, limiting recall, ascertainment, and selection 
bias. Third, we also collected details on several known risk factors for 
CRC that may confound the relationship between the sulfur microbial 
diet and CRC risk, and their inclusion in our multivariate models did 
not significantly alter our estimates. Finally, we were able to demon-
strate that the presence of sulfur-metabolizing bacteria was coupled 
to their functional activity and transcript levels, an attempt to further 
link correlation to underlying biology. 
We acknowledge several limitations. Our study is composed of 
older male health professionals, minimizing heterogeneity and poten-
tially confounding by socioeconomic status. This is particularly note-
worthy given prior evidence of anatomic heterogeneity in CRC risk by 
socioeconomic status.73 However, concern for generalizability is min-
imal because our observations address a possible underlying mech-
anism relating diet to health likely to be substantially present among 
different populations. Despite these challenges, we found compel-
ling evidence that certain foods may modulate the presence and ac-
tivity of sulfur-metabolizing bacteria, likely related to differences in 
energy and substrate availability. Given the observational nature of 
our study, we cannot exclude the possibility of residual confounding; 
however, we carefully adjusted for multiple potential confounders. Al-
though strain-level differences in pathogenic potential and microbial 
transcription have been well-established,74–77 our compiled list of sul-
fur-metabolizing bacteria was limited to species-level taxonomy. This 
was a necessary constraint given our intention to strictly and confi-
dently categorize microbes using both the cross-classification of bac-
terial pangenomes to known, but sparse sulfur enzymes, as well as 
requiring prior, robust experimental evidence of their involvement in 
sulfur metabolism. Finally, we restricted our analysis to microbes of 
sufficient prevalence and abundance in the healthy human gut. Fu-
sobacterium spp were present in only 6 stool samples (mean relative 
abundance: 2.4 × 10–3). This low prevalence is consistent with other 
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large-scale investigations of healthy humans.74 Thus, our analysis did 
not specifically examine Fusobacterium spp. In contrast, Fusobacte-
rium is more abundant among individuals with late-stage colorectal 
neoplasia,72,78–80 especially CRC.79,81 
Dietary modulation of the gut microbiome is of significant appeal 
as a strategy for risk minimization in chronic disease. Further confir-
mation of our findings will benefit from multidisciplinary approaches 
to elucidate the mechanisms that underlie how these phylogeneti-
cally diverse microbes influence intestinal inflammation and tumor-
igenesis. Epidemiologic investigations on whether the sulfur micro-
bial diet influences risk of precursor adenomatous lesions, as well as 
trials in humans testing avoidance of implicated foods, are needed to 
identify at-risk populations and promising targets to ameliorate po-
tential harms, respectively. Our findings may help unify the previously 
observed relationships linking sulfur-metabolizing microbes and CRC 
and offer a plausible mechanism in support of the well-characterized 
link between diet and CRC risk.  
Supplementary Material (Supplementary Tables 1–4) is attached to this archive 
record.
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